Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
IXICO PLC (GB:IXI)
LSE:IXI
Holding GB:IXI?
Track your performance easily
IXI Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range6.35p - 20.40p
Previous Close9.5p
Volume0.00
Average Volume (3M)41.92K
Market Cap
£4.59M
Enterprise Value949.38K
Total Cash (Recent Filing)£4.03M
Total Debt (Recent Filing)£387.00K
Price to Earnings (P/E)―
Beta0.36
Next Earnings
Dec 03, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding48,351,373
10 Day Avg. Volume8,811
30 Day Avg. Volume41,924
Standard Deviation0.16
R-Squared0.05
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.69
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
IXICO plc News
PremiumCompany Announcements
IXICO Secures Major Huntington’s Disease Trial Contract
PremiumCompany Announcements
IXICO Exceeds Market Expectations with New Contracts
PremiumCompany Announcements
IXICO Appoints New CEO Bram Goorden
PremiumCompany Announcements
IXICO Expands Impact in Huntington’s Disease Research
PremiumCompany Announcements
IXICO plc Announces Major Shareholding Change
PremiumCompany Announcements
IXICO Clinches £1m Neuroimaging ContractPremiumCompany Announcements
IXICO Secures Major Contract for Alzheimer’s TrialPremiumCompany Announcements
IXICO Reports Challenges and Strategic Focus in H1 2024Options Prices
Currently, No data available
---
Ownership Overview
7.79%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
92.21% Public Companies and
Individual Investors
IXI FAQ
What was IXICO PLC’s price range in the past 12 months?
IXICO PLC lowest share price was 6.35p and its highest was 20.40p in the past 12 months.
What is IXICO PLC’s market cap?
Currently, no data Available
When is IXICO PLC’s upcoming earnings report date?
IXICO PLC’s upcoming earnings report date is Dec 03, 2024 which is in 74 days.
How were IXICO PLC’s earnings last quarter?
IXICO PLC released its earnings results on May 21, 2024. The company reported -0.029p earnings per share for the quarter, missing the consensus estimate of N/A by -0.029p.
Is IXICO PLC overvalued?
According to Wall Street analysts IXICO PLC’s price is currently Overvalued.
Does IXICO PLC pay dividends?
IXICO PLC does not currently pay dividends.
What is IXICO PLC’s EPS estimate?
IXICO PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IXICO PLC have?
IXICO PLC has 48,351,370 shares outstanding.
What happened to IXICO PLC’s price movement after its last earnings report?
IXICO PLC reported an EPS of -0.029p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.523%.
Which hedge fund is a major shareholder of IXICO PLC?
Currently, no hedge funds are holding shares in GB:IXI
---
IXICO plc Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-50.52%
12-Months-Change
Fundamentals
Return on Equity
-16.99%
Trailing 12-Months
Asset Growth
-16.32%
Trailing 12-Months
Company Description
IXICO PLC
IXICO PLC is a UK-based company. It is engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies. The company's products include Assessa which is a decision-support tool for healthcare professionals looking to diagnose dementia and detect the underlying causes and health- secure online software for clinicians at the point-of-care to support patient-centred, evidence-based decision making and improve the monitoring and treatment of patients. Also, the company offers a web-based system to track imaging-based research study in real time. Most of the company's revenue comes from the United States.
---
Technical Analysis
---